concept

DOPAMINERGIC NEURONS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about DOPAMINERGIC NEURONS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

629Connections

0Hypotheses

0Analyses

50Outgoing

50Incoming

0Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	DOPAMINERGIC NEURONS
Key Genes/Proteins	ACTB, AIF1, AKT, Alpha-Synuclein, ALPHA-SYNUCLEIN, AMPK
Related Diseases	aging, AGING, ALZHEIMER'S DISEASE
Related Pathways	AMPK SIGNALING

Pathway Diagram

graph TD
    DOPAMINERGIC_NEURONS["DOPAMINERGIC NEURONS"]
    DOPAMINERGIC_NEURONS -->|"involved_in"| Parkinson_s_Disease["Parkinson's Disease"]
    DOPAMINERGIC_NEURONS -->|"expressed in"| SUBSTANTIA_NIGRA["SUBSTANTIA NIGRA"]
    DOPAMINERGIC_NEURONS -->|"activates"| NEURON["NEURON"]
    DOPAMINERGIC_NEURONS -->|"depletes"| PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
    DOPAMINERGIC_NEURONS -->|"activates"| MICROGLIA["MICROGLIA"]
    Parkinson_s_Disease -->|"causes"| DOPAMINERGIC_NEURONS
    ALPHA_SYNUCLEIN["ALPHA-SYNUCLEIN"] -->|"contributes to"| DOPAMINERGIC_NEURONS
    Emodin["Emodin"] -.protects against.-> DOPAMINERGIC_NEURONS
    PS_NPs["PS-NPs"] -->|"inhibits"| DOPAMINERGIC_NEURONS
    alpha_synuclein["alpha-synuclein"] -->|"causes"| DOPAMINERGIC_NEURONS
    Cellular_Senescence["Cellular Senescence"] -->|"expressed in"| DOPAMINERGIC_NEURONS
    Polystyrene_Nanoplastics["Polystyrene Nanoplastics"] -->|"targets"| DOPAMINERGIC_NEURONS

Outgoing (180)

Target	Relation	Type	Str
NEURON	contributes_to	cell_type	0.95
Parkinson'S Disease	involved_in	disease	0.95
Parkinson'S Disease	risk_factor_for	disease	0.95
PARKINSON'S DISEASE	depletes	disease	0.95
SUBSTANTIA NIGRA	causes	brain_region	0.95
NEURON	activates	cell_type	0.95
SUBSTANTIA NIGRA	expressed_in	entity	0.95
NEURON	interacts_with	cell_type	0.95
NEURODEGENERATION	activates	process	0.95
SUBSTANTIA NIGRA	associated_with	brain_region	0.95
Parkinson's Disease	involved_in	disease	0.95
MICROGLIA	activates	cell_type	0.95
Parkinson's Disease	biomarker_for	disease	0.92
Substantia Nigra Pars Compacta	expressed_in	cell_type	0.90
Aging	associated_with	phenotype	0.85
Neurodegeneration	involved_in	process	0.85
Motor Dysfunction	involved_in	phenotype	0.85
PARKINSON'S DISEASE	contributes_to	disease	0.80
PARKINSON'S DISEASE	activates	disease	0.80
NEURON	inhibits	cell_type	0.80
Calcium Handling	involved_in	process	0.80
Neurodegeneration	risk_factor_for	process	0.80
NEURODEGENERATION	causes	process	0.80
oxidative stress response	active_in	pathway	0.75
neurodegeneration	activates	disease	0.70
substantia nigra	expressed_in	brain_region	0.70
Parkinson's Disease	associated_with	disease	0.70
substantia nigra pars compacta	expressed_in	brain_region	0.70
mitophagy	expresses	process	0.70
STRIATUM	activates	brain_region	0.65
PARKINSON'S DISEASE	protects_against	disease	0.65
LRRK2	interacts_with	gene	0.65
STEM CELLS	activates	cell_type	0.65
VENTRAL TEGMENTAL AREA	activates	brain_region	0.65
SUBSTANTIA NIGRA	activates	brain_region	0.65
NEURODEGENERATION	associated_with	process	0.65
PARKINSON'S DISEASE	interacts_with	disease	0.65
NEURON	causes	cell_type	0.65
INFLAMMATION	activates	process	0.65
NEURON	expressed_in	cell_type	0.65
NEURON	depletes	cell_type	0.65
PARKINSON'S DISEASE	regulates	disease	0.65
NEURON	implicated_in	cell_type	0.65
ferroptosis	protects_against	process	0.60
Parkinson's disease	activates	disease	0.60
Parkinson's disease	regulates	disease	0.60
neurodegeneration	regulates	disease	0.60
pyroptosis	activates	process	0.60
neuroinflammation	activates	disease	0.60
calcium signaling	active_in	pathway	0.55

Incoming (449)

Source	Relation	Type	Str
lipid accumulation	drives	process	1.00
USP30	protects_against	gene	1.00
Gentiopicroside	protects_against	compound	0.95
ALPHA-SYNUCLEIN	contributes_to	gene	0.95
Parkinson's Disease	causes	disease	0.95
CELLULAR SENESCENCE	associated_with	entity	0.95
Substantia Nigra Pars Compacta	expressed_in	brain_region	0.95
Substantia Nigra Pars Compacta	associated_with	cell_type	0.95
Lipid Accumulation	causes	process	0.95
Parkinson's Disease	associated_with	disease	0.95
Parkinson's Disease	causes	disease	0.95
Alpha-Synuclein Aggregation	causes	process	0.92
Emodin	protects_against	drug	0.91
LNK	regulates	gene	0.90
Lipid Accumulation	associated_with	process	0.90
Lipid Accumulation	expressed_in	process	0.90
Lipid Aggregation	involved_in	process	0.90
alpha-synuclein	causes	protein	0.90
CRSJ	protects_against	drug	0.90
DOPAMINE BIOSYNTHESIS	expressed_in	pathway	0.90
neuroinflammation	causes	process	0.90
METTL3	expressed_in	gene	0.90
Polystyrene Nanoplastics	causes	compound	0.90
neuroinflammation	affects	disease	0.90
Parkinson'S Disease	associated_with	disease	0.90
PS-NPs	inhibits	drug	0.90
OTUD6A	upregulates	gene	0.90
Oxidative Stress	causes	process	0.90
Parkinson'S Disease	causes	disease	0.90
Parkinson's disease	affects	disease	0.90
Polystyrene Nanoplastics	targets	compound	0.90
neurodegeneration	affects	disease	0.90
Cellular Senescence	expressed_in	process	0.90
MPTP	causes	drug	0.88
lipid droplet accumulation	contributes_to	process	0.85
B3GALT4	expressed_in	gene	0.85
Ferroptosis	causes	process	0.85
Astrocytes	interacts_with	cell_type	0.85
oxidative stress	contributes_to	process	0.85
Atremorine	protects_against	drug	0.85
neurotrophic factors	protects_against	protein	0.85
Lipid Droplets	expressed_in	process	0.85
GLUCOCEREBROSIDES	causes	biological_process	0.85
Lipid Droplets	associated_with	process	0.85
Α-SYNUCLEIN	causes	protein	0.85
BHBA	protects_against	compound	0.85
PINK1	protects_against	gene	0.85
Gene Expression	biomarker_for	process	0.85
Cytokines	causes	protein	0.85
Apoptosis	associated_with	process	0.85

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning DOPAMINERGIC NEURONS in their description or question text

No additional research found